Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P09110
UPID:
THIK_HUMAN
Alternative names:
Acetyl-CoA C-myristoyltransferase; Acetyl-CoA acyltransferase; Beta-ketothiolase; Peroxisomal 3-oxoacyl-CoA thiolase
Alternative UPACC:
P09110; G5E935; Q96CA6
Background:
3-ketoacyl-CoA thiolase, peroxisomal, known alternatively as Acetyl-CoA C-myristoyltransferase, Acetyl-CoA acyltransferase, Beta-ketothiolase, and Peroxisomal 3-oxoacyl-CoA thiolase, plays a pivotal role in fatty acid peroxisomal beta-oxidation. It is responsible for the thiolytic cleavage of straight chain 3-keto fatty acyl-CoAs across various chain lengths, facilitating crucial steps in fatty acid metabolism.
Therapeutic significance:
Understanding the role of 3-ketoacyl-CoA thiolase, peroxisomal could open doors to potential therapeutic strategies.